Clinical Trial Update: Serial Hybrid Atrial Fibrillation Ablation [NA]

View source ↗

Summary

The clinical trial NCT01582828 investigating serial hybrid atrial fibrillation ablation has been withdrawn from the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Medisch Spectrum Twente | Conditions: Atrial Fibrillation | NA | Status: WITHDRAWN